As health insurance tax credits near expiration, millions risk losing affordable health coverage, prompting calls for federal intervention to stabilize U.S. healthcare markets and support providers.
The OIG report reveals Medicare overpayments on continuous glucose monitors and supplies, supporting CMS competitive bidding changes to reduce costs and improve payment models in home medical equipment.
MedPAC proposes a 0.5% increase to Medicare physician payments in 2027 amid access and reimbursement debates, highlighting site-neutral payment considerations for hospital outpatient settings.
CMS introduces the ACCESS Model to improve Medicare chronic care with digital health innovation and outcome-based payments starting 2026.
CMS initiates the ACCESS Model, a 10-year voluntary program testing outcome-based payments for Medicare fee-for-service providers, enhancing integrated, tech-supported chronic care.
CMS's finalized Medicare payment rule for home health agencies reduces payments by 1.3% and revises payment methodology following industry feedback, signaling modest future increases but immediate financial challenges.
Explore how Tyson's Lexington plant closure and Medicare choices are reshaping insurance and risk considerations in Nebraska's agriculture and healthcare sectors.
CMS announces a 9.7% increase in Medicare Part B premiums for 2026, affecting individuals earning $109,000 or less. Updates on oncology drug reimbursement and legal challenges to the CMS 340B drug rebate pilot program highlight shifting dynamics in Medicare regulation and healthcare compliance.
CMS has secured significant price reductions on 15 drugs including costly cancer treatments, impacting Medicare Part B pricing and healthcare costs.
U.S. Senators reintroduce Medicare-X Choice Act to create a public health insurance option aimed at expanding coverage, reducing costs, and increasing competition within ACA and Medicare frameworks.
